Influence of methylcobalamin on the vitamin B12 level and manifestations of neuropathy in patients with type 2 diabetes mellitus and metformin-associated vitamin B12 deficiency
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 4
Abstract
Background. Adverse side effect of metformin is disturbance in vitamin B12 metabolism associated with low serum vitamin B12 level. B12 hypovitaminosis is accompanied by peripheral neuropathy. The aim of the study was to determine the effectiveness of methylcobalamin (Diacobal preparation manufactured by Kusum Pharm LLC, Ukraine) in correcting vitamin B12 deficiency in diabetic patients with metformin-associated vitamin B12 deficiency, and to establish its effect on manifestations of diabetic neuropathy. Materials and methods. Thirty patients with type 2 diabetes mellitus and metformin-associated vitamin B12 deficiency (< 190 pg/ml) were examined. Duration of metformin administration was 6.1 years on average, the average dose was 2100 mg/day. Methylcobalamin was administered at a dose of 500 mg three times a day for three months. Determination of vitamin B12 content and assessment of neuropathy manifestations was carried out before and after the course of treatment. Results. After the course of treatment, it was found that the average content of vitamin B12 in the blood serum reached the reference values (312.4 ± 39.8 pg/ml). The positive effect of therapy on the severity of clinical manifestations of peripheral sensory motor neuropathy in the examined patients was revealed: in 17 (56.7 %) patients, the severity of numbness in feet significantly decreased, in 6 (20 %) persons, there was a complete disappearance of numbness. The intensity of the pain syndrome decreased in 19 (63.3 %) patients, the pain syndrome was completely removed in 3 (10 %) persons. Conclusions. The relationship between metformin and B12 hypovitaminosis has been confirmed. Diacobal is an effective and safe drug for the prevention and treatment of metformin-induced vitamin B12 deficiency and diabetic neuropathy.
Authors and Affiliations
V. I. Pankiv
Keywords
Related Articles
- EP ID EP630812
- DOI 10.22141/2224-0721.15.4.2019.174818
- Views 65
- Downloads 0
Optimization of Ultrasonography in Assessing the Heart and Blood Vessels Condition in Patients with Arterial Hypertension with or without Type 2 Diabetes Mellitus
The objective — to study the peculiarities of the heart and blood vessels condition in patients with essential hypertension (EH) with or without type 2 diabetes mellitus. Materials and methods. The study involved 134 pat...
ORIGIN Trial (Background, Results)
ORIGIN — the longest and most extensive study on Lantus® use in patients with cardiovascular risk with diabetes mellitus (DM) type 2 in the early stages, as well as prediabetes, in which insulin therapy is not indicated...
Expression of mRNA IL-1β, IL-17А and IL-10 of oral epithelium in diabetic children
The aim of the study was to investigate the indexes of cytokines profile in the epithelium of oral cavity of children with type 1 diabetes mellitus (DM) taking into account present metabolic violations. Materials and met...
A1chieve® Study: Global problems of Compensation of Diabetes Mellitus Type 2
No abstract
Features of Immune and Metabolic Changes in patients with Combined Endocrine Pathology and Vitamin D3 Deficiency
Aim. To study the cytokines background concentration in patients with combined endocrine pathology — diabetes mellitus (DM) type 1 or 2 and autoimmune thyroiditis secondary to vitamin D3 deficiency. Methods. The examined...